M. Douglas Winship
Keine laufenden Positionen mehr
Profil
Mr. M.
D.
Winship is Vice President-Regulatory Operations at Catalyst Pharmaceutical Partners, Inc.
Mr. Winship was previously employed as VP-Quality Assurance & Regulatory Affairs by Argos Therapeutics, Inc., SVP-Regulatory Affairs & Quality Assurance by CEL-SCI Corp., and VP-Regulatory Affairs & Quality Assurance by Curative Technologies, Inc.
He received his undergraduate degree from Upsala College.
Ehemalige bekannte Positionen von M. Douglas Winship
| Unternehmen | Position | Ende |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | General Counsel | 01.01.2005 |
| CEL-SCI CORPORATION | General Counsel | 01.01.2002 |
Curative Technologies, Inc.
 Curative Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Curative Technologies, Inc. is an American biopharmaceutical research company. | General Counsel | 01.01.1994 |
| CATALYST PHARMACEUTICALS, INC. | General Counsel | - |
Ausbildung von M. Douglas Winship
| Upsala College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| CEL-SCI CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Curative Technologies, Inc.
Curative Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Curative Technologies, Inc. is an American biopharmaceutical research company. | Commercial Services |
